We are the ideal partner when it comes to entering into new markets for specialty pharmaceuticals.

As a marketing partner for pharmaceutical companies, RIEMSER has established highly effective distribution channels in key European regions. We boast many years of experience and have a broad network of contacts with opinion leaders, especially in the indications oncology, dermatology, infectiology, cardiovascular diseases and rheumatology.

Our aim is to strengthen and also to expand our existing distribution channels and networks, both as a license holder and as a purchaser of products, product groups and companies. We have also demonstrated that we are able to successfully launch medicines onto new markets, for example with Tepadina and Aloxi.

Higher returns for your products

The marketing expertise of RIEMSER also covers the expansion of existing therapeutic product indications. By means of systematic life cycle management we increase the earnings period and profitability of medicines. For example, we have profound knowledge of the provisions and regulations that govern international target markets. This know-how enables us to accelerate refund procedures and approvals of new indications.

Profound scientific basis for marketing authorisation

RIEMSER boasts extensive know-how in the marketing authorisation procedure of medicines. An experienced team takes care of European and international marketing authorisations. The close collaborations with renowned research institutes, universities and hospitals in Germany and throughout Europe are a key factor for the success of our authorisation strategies.